论文信息 - FoxO‐1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models - 字舞流文

FoxO‐1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

N. Zaffaroni | P. Perego | N. Carenini | E. Scanziani | M. de Cesare | Y. Landesman | C. Argueta | E. Ciusani | C. Corno | S. Stamatakos | L. Gatti | L. Minoli | Simone Stucchi